These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28101907)

  • 1. Increased Arf/p53 activity in stem cells, aging and cancer.
    Carrasco-Garcia E; Moreno M; Moreno-Cugnon L; Matheu A
    Aging Cell; 2017 Apr; 16(2):219-225. PubMed ID: 28101907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Arf/p53 pathway in cancer and aging.
    Matheu A; Maraver A; Serrano M
    Cancer Res; 2008 Aug; 68(15):6031-4. PubMed ID: 18676821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-aging activity of the Ink4/Arf locus.
    Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
    Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed ageing through damage protection by the Arf/p53 pathway.
    Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
    Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the E2F1-p19-p53 pathway in ischemic acute renal failure.
    Tanaka H; Terada Y; Okado T; Inoshita S; Kuwahara M; Sasaki S
    Nephron Physiol; 2005; 101(2):p27-34. PubMed ID: 15990448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
    Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor dosage regulates stem cell dynamics during aging.
    Gatza C; Moore L; Dumble M; Donehower LA
    Cell Cycle; 2007 Jan; 6(1):52-5. PubMed ID: 17245110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
    Lim IK
    J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor p53: cancer and aging.
    Feng Z; Hu W; Rajagopal G; Levine AJ
    Cell Cycle; 2008 Apr; 7(7):842-7. PubMed ID: 18414039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p19(Arf) is required for the cellular response to chronic DNA damage.
    Bieging-Rolett KT; Johnson TM; Brady CA; Beaudry VG; Pathak N; Han S; Attardi LD
    Oncogene; 2016 Aug; 35(33):4414-21. PubMed ID: 26725325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ink4a/Arf links senescence and aging.
    Sharpless NE
    Exp Gerontol; 2004; 39(11-12):1751-9. PubMed ID: 15582292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress.
    Wang S; Tian C; Xing G; Gao M; Jiao W; Xiao T; Yin Y; He F; Zhang L
    FEBS Lett; 2010 Sep; 584(18):3909-15. PubMed ID: 20713054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
    Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
    Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
    Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
    Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular signaling in normal and cancerous stem cells.
    Grinstein E; Wernet P
    Cell Signal; 2007 Dec; 19(12):2428-33. PubMed ID: 17651940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
    Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
    EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.